Exhibit 5.1
February 2, 2021
Commercial Metals Company
6565 N. MacArthur Blvd., Suite 800
Irving, Texas 75039
Ladies and Gentlemen:
We have acted as counsel to Commercial Metals Company, a Delaware corporation (the “Company”), with respect to the public offering and issuance of $300,000,000 principal amount of the Company’s 3.875% Senior Notes due 2031 (the “Securities”). The Securities are being offered and sold by the Company pursuant to a registration statement on Form S-3 (as amended or supplemented, the “Registration Statement”), filed with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the “Securities Act”), on January 19, 2021 (File No. 333-252191), as supplemented by that certain prospectus supplement dated January 19, 2021 (the “Prospectus Supplement”). The Securities are proposed to be sold to the several underwriters (the “Underwriters”) named in Schedule II to the underwriting agreement, dated January 19, 2021, between the Company and Citigroup Global Markets Inc. as the representative of the several underwriters named therein (the “Underwriting Agreement”).
The Securities are being issued under that certain Indenture (the “Base Indenture”), dated as of May 6, 2013, entered into by the Company and U.S. Bank National Association, as trustee (the “Trustee”), filed as Exhibit 4.1 to the Registration Statement on Form S-3 (File No. 333-188366) filed with the Commission on May 6, 2013, as supplemented by that certain Fourth Supplemental Indenture (the “Fourth Supplemental Indenture”) entered into by the Company and the Trustee, filed as Exhibit 4.1 to the Current Report on Form 8-K filed with the Commission on February 2, 2021.
For purposes of the opinions we express below, we have examined originals, or copies certified or otherwise identified, of: (i) the certificate of incorporation and bylaws, each as amended to date, of the Company, (ii) the Registration Statement and all exhibits thereto, (iii) the Prospectus Supplement, (iv) the minutes and records of the corporate proceedings of the Company with respect to the issuance and sale of the Securities, (v) the Base Indenture, (vi) the Fourth Supplemental Indenture, (vii) the form of global note representing the Securities, (viii) the Underwriting Agreement, and (ix) such other corporate records of the Company as we have deemed necessary or appropriate for purposes of the opinions hereafter expressed.
As to questions of fact material to the opinions expressed below, we have, without independent verification of their accuracy, relied to the extent we deem reasonably appropriate upon the representations and warranties of the Company contained in such documents, and on such records, certificates, instruments or representations furnished or made available to us by the Company.
In making the foregoing examination, we have assumed (i) the genuineness of all signatures, (ii) the authenticity of all documents submitted to us as originals, (iii) the conformity to original documents of all documents submitted to us as certified or photostatic copies, (iv) that all agreements or instruments we have examined are the valid, binding and enforceable obligations of the parties thereto, other than the Company, and (v) that all factual information on which we have relied was accurate and complete.